Preliminary clinical data in post-anti-PD-1 NSCLC patients demonstrated a 27% ORR and 73% DCR in monotherapy trialMonotherapy activity with ...
Gerdau S/A Ord-0.31% R$40.9B ...
“Shall we go out for a relaxing Sunday drive?” said nobody ever, in 2024. Modern cars may be monstrously irritating, with all their bleeps and safety features, but modern motoring in general ...